Skip to content
Raziel Therapuetics
Homepage
About
Science
Clinical Programs
Program Overview
Body Contouring
Dercum’s Disease
Lipedema
Lipoma
News
Contact
Twitter page opens in new window
Facebook page opens in new window
Instagram page opens in new window
Homepage
About
Science
Clinical Programs
Program Overview
Body Contouring
Dercum’s Disease
Lipedema
Lipoma
News
Contact
In November 2019 Raziel received FDA approval to develop RZL-012 as an orphan drug for Dercum’s Disease.
Go to Top
